FORT LAUDERDALE, Fla., Nov. 3, 2010 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets both its RIO® Robotic Arm Interactive Orthopedic surgical platform and proprietary RESTORIS® implants for minimally invasive orthopedic procedures known as knee MAKOplasty®, today announced that it intends, subject to market conditions, to offer common stock pursuant to an underwriting agreement with Piper Jaffray & Co. acting as the sole bookrunner.
